Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study

BACKGROUND: Adherence to disease-modifying therapies (DMTs) results in the reduction of the number and severity of relapses and delays the progression of multiple sclerosis (MS). Patients with lower adherence rates experience more inpatient visits and higher MS-related medical costs. Fingolimod, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Agashivala, Neetu, Wu, Ning, Abouzaid, Safiya, Wu, You, Kim, Edward, Boulanger, Luke, Brandes, David W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851325/
https://www.ncbi.nlm.nih.gov/pubmed/24093542
http://dx.doi.org/10.1186/1471-2377-13-138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851325/
https://www.ncbi.nlm.nih.gov/pubmed/24093542
http://dx.doi.org/10.1186/1471-2377-13-138

Ejemplares similares